Stryker Corp (SYK)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$327.64

Buy

$335.00

arrow-up$2.14 (+0.65%)

Prices updated at 03 Apr 2026, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Stryker Corp is engaged in designing, manufacturing and marketing of medical equipment, instruments, and implantable devices. Its products include hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, and spinal devices.
Sector
Healthcare
Industry
Medical Devices
Chairman
Mr. Kevin A. Lobo
CEO
Mr. Kevin A. Lobo
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
56,000
Head office
1941 Stryker Way
Portage
United States
49002
mobile
+1 269 385-2600
letter
jason.beach@stryker.com

Key personnel

Salary
Ms. Ronda E. Stryker
Independent Director
0.13m
Ms. Sherilyn S. McCoy
Lead Independent Director
0.17m
Ms. Mary K. Brainerd
Independent Director
0.15m
Mr. Andrew K. Silvernail
Independent Director
0.16m
Mr. Kevin A. Lobo
Chairman of the Board and Chief Executive Officer
1.49m
Dr. Giovanni Caforio, M.D.
Independent Director
0.14m
Mr. William E. Berry, Jr
Vice President, Corporate Controller and Chief Accounting Officer
-
Mr. Rajeev Suri
Independent Director
0.13m
Ms. Lisa M. Skeete Tatum
Independent Director
0.13m
Ms. M. Kathryn Fink
Vice President and Chief Human Resources Officer
-
Mr. Viju S. Menon
Group President, Global Quality and Operations
0.68m
Mr. Spencer S. Stiles
President and Chief Operating Officer
0.79m
Mr. Robert S Fletcher
Vice President and Chief Legal Officer
-
Ms. Rachel M. Ruggeri
Independent Director
0.13m
Mr. J. Andrew Pierce
Group President, MedSurg and Neurotechnology
0.79m
Mr. Preston W. Wells
Vice President and Chief Financial Officer
0.65m
Mr. Emmanuel P. Maceda
Independent Director
0.08m
Ms. Kimberly Ann Montagnino
Vice President and Chief Communications Officer
-
Mr. Dylan Bram Crotty
Group President, Orthopaedics
-
Ms. Debra King
Vice President, Chief Digital and Information Officer
-

Top 5 shareholders

No. of shares
Vanguard Group Inc33,907,291
BlackRock Inc26,728,719
JPMorgan Chase & Co23,880,302
Greenleaf Trust16,564,209
State Street Corp14,942,900

Director dealings

Action
16 Dec 2025-
16 Dec 2025-
21 Nov 2025-
21 Nov 2025-
21 Nov 2025-
20 Nov 2025-
14 Nov 2025-
14 Nov 2025-
14 Nov 2025-
14 Nov 2025-
05 Nov 2025-
05 Nov 2025-
06 Nov 2025-
06 Nov 2025-
06 Nov 2025-
06 Nov 2025-
06 Nov 2025-
06 Nov 2025-
06 Nov 2025-
05 Nov 2025-
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.